Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer.

Trial Profile

Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Cisplatin; Everolimus; Vinorelbine
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Apr 2012 Planned end date changed from 1 Jul 2012 to 1 Jul 2014 as reported by ClinicalTrials.gov.
    • 03 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top